A. William Blackstock
Department of Radiation Oncology
Wake Forest University Comprehensive Cancer Center
Winston-Salem
North Carolina 27516
USA
Name/email consistency: high
- Phase Ia/Ib chemo-radiation trial of gemcitabine and dose-escalated thoracic radiation in patients with stage III A/B non-small cell lung cancer. Blackstock, A.W., Ho, C., Butler, J., Fletcher-Steede, J., Case, L.D., Hinson, W., Miller, A.A. J. Thorac. Oncol (2006)
- Similar outcomes between African American and non-African American patients with extensive-stage small-cell lung carcinoma: report from the Cancer and Leukemia Group B. Blackstock, A.W., Herndon, J.E., Paskett, E.D., Miller, A.A., Lathan, C., Niell, H.B., Socinski, M.A., Vokes, E.E., Green, M.R. J. Clin. Oncol. (2006)
- A prospective evaluation of the impact of 18-F-fluoro-deoxy-D-glucose positron emission tomography staging on survival for patients with locally advanced esophageal cancer. Blackstock, A.W., Farmer, M.R., Lovato, J., Mishra, G., Melin, S.A., Oaks, T., Aklilu, M., Clark, P.B., Levine, E.A. Int. J. Radiat. Oncol. Biol. Phys. (2006)
- Adjuvant gemcitabine and concurrent radiation for patients with resected pancreatic cancer: a phase II study. Blackstock, A.W., Mornex, F., Partensky, C., Descos, L., Case, L.D., Melin, S.A., Levine, E.A., Mishra, G., Limentani, S.A., Kachnic, L.A., Tepper, J.E. Br. J. Cancer (2006)
- Pathologic complete response may not represent the optimal surrogate for survival after preoperative therapy for esophageal cancer. Blackstock, A.W., Aklilu, M., Lovato, J., Farmer, M.R., Mishra, G., Melin, S.A., Oaks, T., Geisinger, K., Levine, E.A. Int. J. Gastrointest. Cancer (2006)
- Split-course versus continuous thoracic radiation therapy for limited-stage small-cell lung cancer: final report of a randomized phase III trial. Blackstock, A.W., Bogart, J.A., Matthews, C., Lovato, J.F., McCoy, T., Livengood, K., Ho, C., White, D., Atkins, J.N., Miller, A.A. Clin. Lung. Cancer (2005)
- Cancer and leukemia group B (CALGB) 89805: phase II chemoradiation trial using gemcitabine in patients with locoregional adenocarcinoma of the pancreas. Blackstock, A.W., Tepper, J.E., Niedwiecki, D., Hollis, D.R., Mayer, R.J., Tempero, M.A. Int. J. Gastrointest. Cancer (2003)
- Outcomes among African-American/non-African-American patients with advanced non-small-cell lung carcinoma: report from the Cancer and Leukemia Group B. Blackstock, A.W., Herndon, J.E., Paskett, E.D., Perry, M.C., Graziano, S.L., Muscato, J.J., Kosty, M.P., Akerley, W.L., Holland, J., Fleishman, S., Green, M.R. J. Natl. Cancer Inst. (2002)
- Tumor uptake and elimination of 2',2'-difluoro-2'-deoxycytidine (gemcitabine) after deoxycytidine kinase gene transfer: correlation with in vivo tumor response. Blackstock, A.W., Lightfoot, H., Case, L.D., Tepper, J.E., Mukherji, S.K., Mitchell, B.S., Swarts, S.G., Hess, S.M. Clin. Cancer Res. (2001)
- Phase I study of twice-weekly gemcitabine and concurrent thoracic radiation for patients with locally advanced non-small-cell lung cancer. Blackstock, A.W., Lesser, G.J., Fletcher-Steede, J., Case, L.D., Tucker, R.W., Russo, S.M., White, D.R., Miller, A. Int. J. Radiat. Oncol. Biol. Phys. (2001)
- Phase II study of pyrazine diazohydroxide (NSC 361456) for advanced non small-cell lung cancer. Blackstock, A.W., Acostamadiedo, J., Lesser, G., Richards, F., Case, L.D., White, D.R. Clin. Lung. Cancer (2000)
- Phase I trial of twice-weekly gemcitabine and concurrent radiation in patients with advanced pancreatic cancer. Blackstock, A.W., Bernard, S.A., Richards, F., Eagle, K.S., Case, L.D., Poole, M.E., Savage, P.D., Tepper, J.E. J. Clin. Oncol. (1999)
- Twice-weekly gemcitabine and concurrent thoracic radiation for advanced non small-cell lung cancer. Blackstock, A.W., Richards, F., White, D., Lesser, G. Clin. Lung. Cancer (1999)
